Idiopathic Hypersomnia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NLSP | F | NLS Pharmaceutics Ltd. | -3.45 | |
ZVRA | F | Zevra Therapeutics, Inc. | -0.22 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | C | iShares Microcap ETF | 0.04 | |
IWM | C | iShares Russell 2000 ETF | 0.01 | |
IWN | C | iShares Russell 2000 Value ETF | 0.01 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 4 | ZVRA | Zevra Therapeutics files for $350M mixed shelf |
- Idiopathic Hypersomnia
Idiopathic hypersomnia (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness (EDS). The condition typically becomes evident in early adulthood and most patients diagnosed with IH will have had the disorder for many years prior to their diagnosis. As of August 2021, an FDA-approved medication exists for IH, in addition to several off-label treatments (primarily FDA-approved narcolepsy medications).Idiopathic hypersomnia may also be referred to as IH, IHS, or primary hypersomnia and belongs to a group of sleeping disorders known as central hypersomnias, central disorders of hypersomnolence, or hypersomnia of brain origin. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) defines idiopathic hypersomnia as EDS without narcolepsy or the associated features of other sleep disorders. It occurs in the absence of medical problems or sleep disruptions, such as sleep apnea, that can cause secondary hypersomnia.
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles